By Iain Gilbert
Date: Thursday 17 Apr 2025
(Sharecast News) - Clinical diagnostics firm Lunglife said on Thursday that it has entered into a conditional exclusive license agreement for the commercial distribution of its LungLB test in the US.
Lunglife said the agreement with liquid biopsy diagnostics outfit Circulogene Theranostics meant it will "shortly" receive an advance payment of...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news